Publication | Closed Access

Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial

Heart FailureKinesiologyPhysical ActivityExerciseExercise PhysiologyPhysiologyPhysical ExerciseApplied PhysiologyPharmacotherapyExercise End PointClinical ExerciseExercise ScienceMedicineVasopressin AntagonistChf PatientsHealth Sciences